Sonnet BioTherapeutics Holdings, Inc. (SONN)


Stock Price Forecast

May 3, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sonnet BioTherapeutics Holdings, Inc. chart...

About the Company

We do not have any company description for Sonnet BioTherapeutics Holdings, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

6

Exchange

Nasdaq

$8M

Total Revenue

6

Employees

$6M

Market Capitalization

-3.46

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SONN News

Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference

1d ago, source:

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company developing innovative targeted biologic ...

Sonnet BioTherapeutics Holdings, Inc.

4mon ago, source: CNN

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a ...

Sonnet BioTherapeutics Holdings Inc Ordinary Shares SONN

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sonnet BioTherapeutics Holdings Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference

4d ago, source: Business Insider

Minneapolis, Minnesota--(Newsfile Corp. - May 3, 2024) - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs ...

Sonnet BioTherapeutics Holdings Inc.

2y ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Sonnet BioTherapeutics Holdings, Inc. Common Stock (SONN)

3y ago, source: Nasdaq

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Sonnet BioTherapeutics Holdings Inc Ordinary Shares

8d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sonnet BioTherapeutics Holdings, Inc. (SONN)

10d ago, source: Yahoo Finance

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Sonnet BioTherapeutics Holdings, Inc. (SONN)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...